ZINECARD
Google image searchProduct monograph
Active ingredient
dexrazoxane, 250 MG/VIAL
DIN: 02153432
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 03-FEB-2009
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AF — Detoxifying agents for antineoplastic treatment (ATC, ATC/DDD)
- V03AF02 — DEXRAZOXANE (ATC/DDD)
Reference brand drug: Zinecard
Pharmaceutical standard: USP
